The emergence of cephalosporin-resistant gonorrhea in the United States would make gonorrhea much more difficult to treat.
Gonorrhea has progressively developed resistance to the antibiotic drugs prescribed to treat it. The emergence of cephalosporin-resistant gonorrhea would significantly complicate our ability to treat gonorrhea successfully, since we have few antibiotic options left that are simple, well-studied, and highly effective. It is critical to continuously monitor antibiotic resistance in Neisseria gonorrhoeae and encourage research and development of new treatment regimens.
View Basic Information »
Data, trends, challenges, and lab information
Recent Press Coverage about Drug Resistant Gonorrhea (May 8, 2013)
Cephalosporin-Resistant Gonorrhea in North America - JAMA editorial by Robert D. Kirkcaldy, MD, MPH (January 9, 2013)
Gonococcal Isolate Surveillance Project (GISP) Profiles 2011 (December 17, 2012)
STD Surveillance 2011 - Gonorrhea (December 13, 2011)
New Treatment Guidelines for Gonorrhea: Antibiotic Change - CDC expert commentary featuring Dr. Robert Kirkcaldy (August 13, 2012)
Update to CDC’s 2010 Sexually Transmitted Disease Treatment Guidelines: Oral Cephalosporins No Longer Recommended Treatment for Gonococcal Infections – MMWR August 10, 2012 (August 9, 2012)
Audio Podcast - Dr. Robert Kirkcaldy, lead author, discusses updates to CDC’s gonorrhea treatment guidelines in this three minute audio podcast.
> Press Release - Media announcement about updated gonorrhea treatment guidelines, includes quotes from NCHHSTP leadership
> Media fact sheet - Details changes to updated gonorrhea treatment, gonorrhea trends, and call to action (updated December 2012)